1. P637 Targeting mucosal healing: dose optimization of Vedolizumab in IBD patients with inadequate endoscopic response to standard dosing. (30th January 2023) Authors: Dal Buono, A; Gabbiadini, R; Migliorisi, G; Solitano, V; Canziani, L; Repici, A; Armuzzi, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗